2022 - Research.com Psychology in Spain Leader Award
2022 - Research.com Medicine in Spain Leader Award
The scientist’s investigation covers issues in Bipolar disorder, Psychiatry, Mania, Clinical psychology and Internal medicine. Eduard Vieta mostly deals with Bipolar I disorder in his studies of Bipolar disorder. His work on Randomized controlled trial expands to the thematically related Psychiatry.
The Mania study combines topics in areas such as Risperidone, Electroconvulsive therapy and Adjunctive treatment. His Clinical psychology research incorporates elements of Psychosocial, Verbal learning, Cognition and Cognitive disorder. The concepts of his Internal medicine study are interwoven with issues in Placebo, Endocrinology and Mood stabilizer.
His primary scientific interests are in Bipolar disorder, Psychiatry, Clinical psychology, Internal medicine and Mania. Eduard Vieta focuses mostly in the field of Bipolar disorder, narrowing it down to matters related to Schizophrenia and, in some cases, Psychosis. His research on Psychiatry frequently connects to adjacent areas such as Psychotherapist.
His research in Clinical psychology intersects with topics in Neuropsychology, Psychosocial, Verbal memory, Neurocognitive and Comorbidity. The various areas that Eduard Vieta examines in his Internal medicine study include Young Mania Rating Scale, Placebo and Mood stabilizer. His Mania research integrates issues from Lamotrigine and Risperidone.
His scientific interests lie mostly in Bipolar disorder, Clinical psychology, Psychiatry, Internal medicine and Schizophrenia. His research on Bipolar disorder focuses in particular on Mania. His biological study spans a wide range of topics, including Verbal memory, Cognition, Neuropsychology, Psychosocial and Cronbach's alpha.
All of his Psychiatry and Mental health and Anxiety investigations are sub-components of the entire Psychiatry study. His Internal medicine research incorporates themes from Placebo and Oncology. His study in Schizophrenia is interdisciplinary in nature, drawing from both Psychosis, Genome-wide association study, Neuroimaging and Bipolar I disorder.
His scientific interests lie mostly in Bipolar disorder, Clinical psychology, Psychiatry, Schizophrenia and Cognition. Particularly relevant to Bipolar I disorder is his body of work in Bipolar disorder. His study looks at the relationship between Clinical psychology and fields such as Verbal memory, as well as how they intersect with chemical problems.
His Psychiatry study integrates concerns from other disciplines, such as Young adult and PsycINFO. The study incorporates disciplines such as Psychosis, Genome-wide association study, Neuroimaging and Autism spectrum disorder in addition to Schizophrenia. Eduard Vieta combines subjects such as Oncology and Depression with his study of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.
Anabel Martínez-Arán;Eduard Vieta;María Reinares;Francesc Colom.
American Journal of Psychiatry (2004)
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter.
Archives of General Psychiatry (2003)
A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission
Francesco Colom;Eduard Vieta;Anabel Martínez-Arán;María Reinares.
Archives of General Psychiatry (2003)
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients
Jules Angst;Rolf Adolfsson;Franco Benazzi;Alex Gamma.
Journal of Affective Disorders (2005)
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
G. M. Goodwin;P. M. Haddad;I. N. Ferrier;J. K. Aronson.
Journal of Psychopharmacology (2009)
Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.
A Martínez-Arán;E Vieta;F Colom;C Torrent.
Bipolar Disorders (2004)
Functional outcome in bipolar disorder: the role of clinical and cognitive factors
A Martinez-Aran;E Vieta;C Torrent;J Sanchez-Moreno.
Bipolar Disorders (2007)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh.
Bipolar Disorders (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N Yatham;Sidney H Kennedy;Sagar V Parikh;Ayal Schaffer.
Bipolar Disorders (2018)
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: